您的位置: 首页 > 农业专利 > 详情页

Peptide vaccines based on the EGFRvIII sequence for the treatment of tumors
专利权人:
The Board of Trustees of the Leland Stanford Junior University
发明人:
Albert J. Wong
申请号:
US14417752
公开号:
US09694060B2
申请日:
2013.08.02
申请国别(地区):
US
年份:
2017
代理人:
摘要:
Peptides and vaccine compositions comprising peptides based upon EGFRvIII and lacking a glycine at the splice junction are disclosed. The vaccines can induce immune responses against EGFRvIII. Methods of inhibiting formation or growth of EGFvIII tumors, methods of inducing regression of EGFvIII tumors, methods of immunizing against EGFvIII tumors and methods of treating a subjects who have EGFvIII tumors are disclosed.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充